ANNX as of Nov 2 · 16:32 ET
ANNXNasdaqPharmaceutical Preparations
Annexon, Inc. · Brief
Next report
7 days
Nov 9 · after closeest.Q3 FY26
Expected move
No implied move.
0 of 7≥ implied
- avg implied
- ±22.3%
- avg realized
- ±3.2%
Nov 14 '24±12.1%▼−3.32%×0.27
Mar 3 '25—▲+3.35%—
May 12 '25±34.0%▼−1.13%×0.03
Aug 14 '25±15.5%▲+2.52%×0.16
Q3 FY25±15.8%▼−0.34%×0.02
Q1 FY26±13.7%▲+11.69%×0.85
May 7 '26±53.1%▲+3.08%×0.06
Q2 FY26±11.9%▼−0.19%×0.02
quarterimplied−55%0+55%realized×
Q2 FY26±11.9%▼−0.19%×0.02
May '26±53.1%▲+3.08%×0.06
Q1 FY26±13.7%▲+11.69%×0.85
Q3 FY25±15.8%▼−0.34%×0.02
Aug '25±15.5%▲+2.52%×0.16
May '25±34.0%▼−1.13%×0.03
2 older reports
Mar '25—▲+3.35%—
Nov '24±12.1%▼−3.32%×0.27
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
ANNX report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.